home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Requirements of the Master Production Record - Webinar By GlobalCompliancePanel

 
  March 16, 2011  
     
 


GlobalCompliancePanel, Online Training Webinar
2011-05-18


Overview: This program will address the 21CFR and Eudralex Volume 4 requirements and interpretation, as well as FDA Guidance regarding the creation, review and approval, and control of Master Production Records.

The material will enable attendees to establish a consistent approach to the design of MPR, including cover page content, instructions, processing requirements and limits, and signature expectations. (There will also be a note on Device Master Record.) In addition to learning what is meant by "list of components", the session will cover attachments and documentation expectations. Finally, the webinar will review the process and requirements for issuance and handling of Batch Production Records (BPR), and clearly describe the difference between the master and the batch production record.

Why should you attend: All the requirements for the master production record (MPR) are based on relevant US and EU regulations. Failure to recognize and implement those requirements can have devastating effects on your company's quality system, including production and manufacturing controls. The purpose of this webinar is to provide attendees with the mandatory compliance requirements for the master production records. Applicable areas may include clinical, technology transfer, and routine manufacturing and packaging for the API and finished commercial product. It is the intent of this program to enable your firm to have a consistent, compliant approach and maintain continuous improvement in the area of production records. With the information gained from this presentation, your company's policy or standard for MPR's will comply with the regulations and you can be assured that you will be working within the intent of and meeting these regulatory requirements. Most importantly, by complying with these regulations, you are ultimately helping to provide a better product for your patients.

Areas Covered in the Session:
  • Regulatory Expectation (FDA and EU)
  • Creation and Revision of Master Production Record (MPR)
  • Review and Approval of MPR
  • Content of the MPR
  • Issuance of BPR
  • Device Master Record (DMR)
  • Roles and Responsibilities
Who Will Benefit:
  • Manufacturing (production and packaging)
  • Quality Assurance
  • Validation
  • Materials Management
  • Quality Control
  • Regulatory Affairs
 
 
Organized by: GlobalCompliancePanel
Invited Speakers: Kerry gained his pharmaceutical manufacturing experience during his 28-year career with Merck. His career spanned the areas of Quality Operations, Audits & Inspections, Laboratory, Human Resources, and Learning & Development. More specifically, his responsibilities included quality management of laboratory assessment, site GMP lead auditor, FDA QSIT/Quality Management System manager, 5S coordinator, GMP trainer (annual, ongoing, new hire), OSHA regulations and Process Safety Management training, as well as internal and external public relations.
 
Deadline for Abstracts: 2011-05-18
 
Registration: Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.